# Avicena LVDP Validation Study

> **NCT05633004** · NA · COMPLETED · sponsor: **Avicena LLC** · enrollment: 406 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Vivio

## Key facts

- **NCT ID:** NCT05633004
- **Lead sponsor:** Avicena LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-27
- **Primary completion:** 2022-09-08
- **Final completion:** 2022-09-30
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2022-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633004, "Avicena LVDP Validation Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05633004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*